Quantitative 3-dimensional contrast echocardiographic determination of myocardial mass at risk and residual infarct mass after reperfusion: Experimental canine studies with intravenous contrast agent NC100100

Journal of the American Society of Echocardiography

Volumn 13, Issue 6, 2000, Pages 570-581

  Yao, Jiefen ^a   Teupe, Claudius ^a   Takeuchi, Masaaki ^a   Avelar, Erick ^a   Sheahan, Malachi ^a   Connolly, Raymond ^a   Ostensen, Jonny ^a   Pandian, Natesa G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NC 100100;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; HEART INFARCTION; HEART MUSCLE REPERFUSION; NONHUMAN; QUANTITATIVE DIAGNOSIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033916863     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/mje.2000.104646     Document Type: Article

References (31)

1. Mahmarian JJ. Prediction of myocardium at risk: clinical significance during acute infarction and in evaluating subsequent prognosis. Cardiol Clin. 13:1995;355-378.
2. Kaul S, Villanueva FS. Is the determination of myocardial perfusion necessary to evaluate the success of reperfusion when the infarct-related artery is open? Circulation. 85:1992;1942-1944.
3. Kaul S, Glasheen WP, Ruddy TD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. Circulation. 75:1987;1249-1260.
4. Taylor AL, Kieso RA, Melton J, Hite P, Pandian NG, Kerber RE. Echocardiographically detected dyskinesis, myocardial infarct size, and coronary risk region relationships in reperfused canine myocardium. Circulation. 71:1300;1292-1300.
5. Kerber RE, Marcus ML, Ehrhardt J, Wilson R, Abboud FM. Correlation between echocardiographically demonstrated segmental dyskinesis and regional myocardial perfusion. Circulation. 52:1975;1097-1104.
6. Johnston BJ, Blinston GE, Jugdutt BI. Overestimation of myocardial infarct size due to remodeling of the infarct zone. Can J Cardiol. 10:1994;77-86.
7. Kaul, S, 1995, Dobutamine echocardiography for determining myocardial viability after reperfusion: experimental and clinical observations.
8. Charney R, Schwinger ME, Chun J, Cohen MV, Nanna M, Menegus MA. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J. 128:1994;864-869.
9. Santoro GM, Bisi G, Sciagra R, Leoncini M, Fazzini PF, Meldolesi U. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol. 15:1990;301-314.
10. Ryan T, Tarver RD, Duerk JL, Sawada SG, Hollenkamp NC. Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging. J Am Coll Cardiol. 15:1990;1355-1364.
11. Rumberger, JA, Bell, MR, 1992, Measurement of myocardial perfusion and cardiac output using intravenous injection methods by ultrafast (cine) computed tomography.
12. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 87:1993;1-20.
13. Kaul S, Gillam LD, Weyman AE. Contrast echocardiography in acute myocardial ischemia: II. the effect of site of injection of contrast agent on the estimation of area at risk for necrosis after coronary occlusion. J Am Coll Cardiol. 6:1985;825-830.
14. Reisner SA, Ong LS, Lichtenberg GS, Amico AF, Shapiro JR, Allen MN. Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans. J Am Coll Cardiol. 14:1989;660-665.
15. Skyba DM, Jayaweera AR, Goodman NC, Ismail S, Camarano G, Kaul S. Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast: implications for venous injection. Circulation. 90:1994;1513-1521.
16. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol. 26:1995;1340-1347.
17. Firschke C, Lindner JR, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second generation echocardiographic contrast agent. Circulation. 96:1997;959-967.
18. Yao J, Cao QL, Masani N, Delabays A, Magni G, Acar P. Three-dimensional echocardiographic estimation of infarct mass based on quantification of dysfunctional left ventricular mass. Circulation. 96:1997;1660-1666.
19. De Castro, S, Yao, J, Magni, G, Cacciootti, L, Trambaiolo, P, De Sanctis, M1998Three-dimensional echocardiographic assessment of the extension of dysfunctional mass in patients with coronary artery disease.
20. Linka AZ, Ates G, Wei K, Firoozan S, Skyba DM, Kaul S. Three-dimensional myocardial contrast echocardiography: validation of in vivo risk and infarct volumes. J Am Coll Cardiol. 30:1997;1892-1899.
21. Kasprzak JD, Vletter WB, Roelandt JRTC, van Meegen JR, Johnson R, Ten Cate. Visualization and quantification of myocardial mass at risk using three-dimensional contrast echocardiography. Cardiovasc Res. 40:1998;314-321.
22. Delabays, A, Cao, QL, Yao, J, Magni, G, Kanojia, A, Acar, P1996Contrast three-dimensional echocardiography in acute myocardial infarction: 3-D reconstruction of perfusion defects yields accurate estimate of infarct mass and extent [abstract].
23. Masani, ND, Yao, J, Cao, QL, Vannan, MA, Meija, LD, Johnson, D1997Accurate infarct size estimation using NC100100 in mixed coronary territories: increased accuracy of three-dimensional echo vs two-dimensional echo [abstract].
24. Nanto S, Lim YJ, Masuyama T, Hori M, Nagata S. Diagnostic performance of myocardial contrast echocardiography for detection of stunned myocardium. J Am Soc Echocardiogr. 9:1996;314-319.
25. Villarraga HR, Foley DA, Aeschbacher BC, Klarich KW, Mulvagh SL. Destruction of contrast microbubbles during ultrasound imaging at conventional power output. J Am Soc Echocardiogr. 10:1997;783-791.
26. Porter TR, Li S, Kricsfeld D, Armbruster RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol. 29:1997;791-799.
27. Wei K, Skyba DM, Firschke C, Jayaweera AR, Lindner JR, Kaul S. Interactions between microbubbles and ultrasound: In vitro and in vivo observations. J Am Coll Cardiol. 29:1997;1081-1088.
28. Nosir YFM, Lequin MH, Kasprzak JD, van Domburg RT, Vletter WB, Yao J. Measurements and day-to-day variabilities of left ventricular volumes and ejection fraction by three-dimensional echocardiography and comparison with magnetic resonance imaging. Am J Cardiol. 82:1998;209-214.
29. Nosir YFM, Fioretti PM, Vletter WB, Boersma E, Salustri A, Postma JT. Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography: a comparison with radionuclide angiography. Circulation. 94:1996;460-466.
30. Sklenar J, Camarano G, Goodman NC, Ismail S, Jayaweera AR, Kaul S. Contractile versus microvascular reserve for the determination of the extent of myocardial salvage after reperfusion: the effect of residual coronary stenosis. Circulation. 94:1996;1430-1440.
31. Villanueva FS, Camarano G, Ismail S, Goodman NC, Sklenar J, Kaul S. Coronary reserve abnormalities in the infarcted myocardium: assessment of myocardial viability immediately versus late after reflow by contrast echocardiography. Circulation. 94:1996;748-754.